Vivotek Inc. (3454.TW)
TWD 112.5
(-1.75%)
TWD 112.5
(-1.75%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.63 Billion | 468.39 Million | 121.76 Million | 501.4 Million | 808.77 Million | 73.67 Million |
| Net Income | 489.27 Million | 831.6 Million | 200.72 Million | 276.83 Million | 308.86 Million | 318.99 Million |
| Depreciation & Amortization | 179.75 Million | 177.21 Million | 193.67 Million | 228.03 Million | 224.74 Million | 126.6 Million |
| Deferred income taxes | - | - | - | -43.73 Million | -69.78 Million | -82.56 Million |
| Stock-based compensation | - | - | - | -923 Thousand | 40.8 Million | -6.9 Million |
| Change in working capital | 1.08 Billion | -519.15 Million | -165.51 Million | 37.84 Million | 299.77 Million | -283.92 Million |
| Other non-cash items | -112.85 Million | -21.26 Million | -107.11 Million | 3.35 Million | 4.36 Million | 1.46 Million |
| Investing Cash Flow | -34.05 Million | -74.28 Million | -312.22 Million | -26.42 Million | -220.04 Million | -422.37 Million |
| Investments in PPE | -122.87 Million | -99.69 Million | -96.68 Million | -73.26 Million | -175.77 Million | -396.5 Million |
| Acquisitions | 89.19 Million | 9.41 Million | 1.43 Million | 7.24 Million | 7000.00 | 1.69 Million |
| Investment purchases | - | -9.41 Million | -197.14 Million | 43.65 Million | -31.23 Million | -33 Thousand |
| Sales/Maturities of investments | - | 12.35 Million | 178 Thousand | -32.01 Million | -7000.00 | 30.73 Million |
| Other Investing Activities | -380 Thousand | 13.05 Million | -20 Million | 27.96 Million | -13.04 Million | -58.26 Million |
| Financing Cash Flow | -427.76 Million | -379.82 Million | -226.11 Million | -58.94 Million | -364.51 Million | -37.41 Million |
| Debt repayment | -95.23 Million | -224.15 Million | -19.1 Million | -18.92 Million | -107.95 Million | -7.27 Million |
| Dividends payments | -476.12 Million | -121.19 Million | -173.13 Million | -215.58 Million | -210.32 Million | -327.22 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 143.59 Million | -34.47 Million | -33.87 Million | 175.56 Million | -46.22 Million | 297.07 Million |
| Accounts receivables | 523.15 Million | -992.32 Million | 343.84 Million | 60.27 Million | -98.36 Million | 228.73 Million |
| Accounts payables | -849.19 Million | 706.97 Million | 730.93 Million | -205.32 Million | 22.98 Million | -44.84 Million |
| Inventory | 1.13 Billion | -522.26 Million | -1.17 Billion | 31.26 Million | 233.83 Million | -395.42 Million |
| Other working capital | 276.64 Million | 288.46 Million | -63.67 Million | 151.62 Million | 141.31 Million | 111.5 Million |
| Cash at beginning of period | 1.04 Billion | 994.89 Million | 1.42 Billion | 1.02 Billion | 807.71 Million | 1.18 Billion |
| Cash at end of period | 2.22 Billion | 1.04 Billion | 994.89 Million | 1.42 Billion | 1.02 Billion | 807.71 Million |
| Capital Expenditure | -122.87 Million | -99.69 Million | -96.68 Million | -73.26 Million | -175.77 Million | -396.5 Million |
| Effect of forex changes on cash | -1.59 Million | 35.63 Million | -13.54 Million | -14.23 Million | -8.7 Million | 8.28 Million |
| Net cash flow / Change in cash | 1.17 Billion | 49.92 Million | -430.11 Million | 401.8 Million | 215.5 Million | -377.83 Million |
| Free Cash Flow | 1.51 Billion | 368.7 Million | 25.08 Million | 428.14 Million | 632.99 Million | -322.83 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 120.1 Million | 26.04 Million | 1.94 Million | 84.08 Million | 489.27 Million | 181.15 Million |
| Depreciation & Amortization | 39.12 Million | 40 Million | 36.66 Million | 44.42 Million | 179.75 Million | 46.98 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -446.1 Million | 212.78 Million | -152.1 Million | 308.69 Million | 1.08 Billion | 498.5 Million |
| Other non-cash items | -35.42 Million | -174.85 Million | 28.84 Million | 6.14 Million | -112.85 Million | 7.87 Million |
| Investing Cash Flow | -20.32 Million | -22.78 Million | -14.66 Million | -55.21 Million | -34.05 Million | -24.56 Million |
| Investments in PPE | -12.9 Million | -22.6 Million | -16.28 Million | -55.29 Million | -122.87 Million | -22.71 Million |
| Acquisitions | - | - | - | - | 89.19 Million | 110 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -10.06 Million | -172 Thousand | 1.62 Million | 72 Thousand | -380 Thousand | -1.96 Million |
| Financing Cash Flow | -180.47 Million | -184.35 Million | -36.04 Million | -65.7 Million | -427.76 Million | -330.37 Million |
| Debt repayment | -153.16 Million | -162.02 Million | -30.18 Million | -59.56 Million | -95.23 Million | -106.2 Million |
| Dividends payments | -328.95 Million | - | - | - | -476.12 Million | -476.12 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -333.64 Million | -16.28 Million | 21 Thousand | -6.13 Million | 143.59 Million | 251.95 Million |
| Accounts receivables | -138.34 Million | -55.61 Million | -41.01 Million | -132.4 Million | 523.15 Million | 33.49 Million |
| Accounts payables | -64 Million | 213.78 Million | -42.86 Million | -179.86 Million | -849.19 Million | -60.63 Million |
| Inventory | -288.26 Million | 14.99 Million | 124.26 Million | 137.92 Million | 1.13 Billion | 467.85 Million |
| Other working capital | -19.5 Million | 39.61 Million | -192.5 Million | 483.03 Million | 276.64 Million | 57.78 Million |
| Cash at beginning of period | 2.06 Billion | 2.06 Billion | 2.22 Billion | 1.91 Billion | 1.04 Billion | 1.52 Billion |
| Cash at end of period | 1.53 Billion | 2.06 Billion | 2.06 Billion | 2.22 Billion | 2.22 Billion | 1.91 Billion |
| Capital Expenditure | -12.9 Million | -22.6 Million | -16.28 Million | -55.29 Million | -122.87 Million | -22.71 Million |
| Effect of forex changes on cash | -6.09 Million | 4.32 Million | 15.25 Million | -19.64 Million | -1.59 Million | 13.2 Million |
| Net cash flow / Change in cash | -529.19 Million | -5.67 Million | -153.04 Million | 302.78 Million | 1.17 Billion | 392.78 Million |
| Free Cash Flow | -335.2 Million | 174.53 Million | -133.88 Million | 388.06 Million | 1.51 Billion | 711.8 Million |
ROAOF
002082
STARHEALTH
MNPR3
IMB
AST